Cell-line development enhances biopharmaceutical production capacity and quality, but complex biologics like bsAbs and ADCs ...

A senior oncologist explains why in India, where the cancer burden continues to rise, these advancements carry heightened ...

The conglomerate received the top environmental, social, and governance honour from the television broadcaster.

The global bioconjugation market is projected to grow at an estimated CAGR of close to 13% over the next five years. This growth is fueled by the rising need for targeted therapies, continuous ...

As clinical research evolves, disruptive trial designs are reshaping how oncology advances. By integrating novel ...

Facing fierce pricing pressure and flat growth in the US generics market, major Indian pharma companies like Sun Pharma and Dr Reddy's are strategically pivoting toward complex generics, specialty ...

The first-line standard of care for HR-positive/HER2-negative breast cancer is cyclin-dependent kinase (CDK)4/6 inhibitors combined with endocrine therapy (ET). This dual-therapy targets a pathway ...

Ms. Angel Sze, Company Secretary and Head of ESG Management Committee of Fosun International, accepted the “Outstanding ESG Award” on behalf of the company and subsequently joined representatives from ...

With the advent of AI-powered protein design tools, protein-based therapeutics may no longer be constrained by the limits imposed by natural selection.

This article is presented by EFPIA with the support of AbbVie I made a trip back to Europe recently, where I spent the vast ...

Leading private healthcare provider, HCA Healthcare UK (HCA UK), is now live with MEDITECH Expanse across its 11 acute facilities and dozens of outpatient locations, enhancing patient safety and ...

Discusses Oncology Pipeline Advances and Phase III Clinical Updates at Science and Technology Day December 15, ...